Antitumor activity of a novel Aurora A/B kinases inhibitor TY-011 against gastric cancer by inducing DNA damage

被引:1
|
作者
Jiang Tongtong [1 ]
Liu Wang [1 ]
Lu Yu [2 ]
Fang Yanfen [1 ]
Chen Rui [1 ]
Zhang Wanli [1 ]
Liu Xuan [3 ]
Zhang Xiongwen [1 ]
机构
[1] East China Normal Univ, Shanghai Engn Res Ctr Mol Therapeut & New Drug De, Sch Chem & Mol Engn, Shanghai 200062, Peoples R China
[2] Nanjing Tianyi Biosci Co Ltd, Dept Project Management, Nanjing, Peoples R China
[3] Shanghai Univ Tradit Chinese Med, Inst Interdisciplinary Integrat Biomed Res, Shanghai, Peoples R China
关键词
apoptosis; Aurora A; B kinases inhibitor; DNA damage; gastric cancer cells; TY-011; B KINASE; APOPTOSIS;
D O I
10.1097/CAD.0000000000000928
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
TY-011, a novel Aurora A/B kinases inhibitor, was found in our previous study to exhibit prominent inhibitory effects on growth of gastric cancer, both in vitro and in vivo. To clarify the mechanisms of TY-011 in inhibiting proliferation of gastric cancer cells, the effects of TY-011 on mitosis, cell cycle, apoptosis and cellular DNA were checked in the present study. Our results showed that TY-011 treatment induced aberrant mitosis, G2/M phase arrest and apoptosis. Importantly, TY-011 induced evident DNA damage in MGC-803 and MKN-45 human gastric cancer cells, which was further characterized as DNA double-strand break. Furthermore, cells treated with TY-011 appeared to generate multiple spindle fibers emanating from several spindle poles, leading to poly-merotelic kinetochore. These results suggested that TY-011 induced abnormal microtubule-kinetochores attachment and thus DNA damage, apoptosis and finally inhibition of cell proliferation of human gastric cancer cells.
引用
收藏
页码:440 / 451
页数:12
相关论文
共 50 条
  • [1] Antitumor activity of TY-011 against gastric cancer by inhibiting Aurora A, Aurora B and VEGFR2 kinases
    Wang Liu
    Yu Lu
    Xiaoping Chai
    Xiao Liu
    Tong Zhu
    Xihan Wu
    Yanfen Fang
    Xuan Liu
    Xiongwen Zhang
    Journal of Experimental & Clinical Cancer Research, 35
  • [2] Antitumor activity of TY-011 against gastric cancer by inhibiting Aurora A, Aurora B and VEGFR2 kinases
    Liu, Wang
    Lu, Yu
    Chai, Xiaoping
    Liu, Xiao
    Zhu, Tong
    Wu, Xihan
    Fang, Yanfen
    Liu, Xuan
    Zhang, Xiongwen
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2016, 35 : 1 - 15
  • [3] Antitumor Activity of KW-2450 against Triple-Negative Breast Cancer by Inhibiting Aurora A and B Kinases
    Kai, Kazuharu
    Kondo, Kimie
    Wang, Xiaoping
    Xie, Xuemei
    Pitner, Mary K.
    Reyes, Monica E.
    Torres-Adorno, Angie M.
    Masuda, Hiroko
    Hortobagyi, Gabriel N.
    Bartholomeusz, Chandra
    Saya, Hideyuki
    Tripathy, Debu
    Sen, Subrata
    Ueno, Naoto T.
    MOLECULAR CANCER THERAPEUTICS, 2015, 14 (12) : 2687 - 2699
  • [4] Antitumor activity of the aurora a selective kinase inhibitor, alisertib, against preclinical models of colorectal cancer
    Pitts, Todd M.
    Bradshaw-Pierce, Erica L.
    Bagby, Stacey M.
    Hyatt, Stephanie L.
    Selby, Heather M.
    Spreafico, Anna
    Tentler, John J.
    McPhillips, Kelly
    Klauck, Peter J.
    Capasso, Anna
    Diamond, Jennifer R.
    Davis, S. Lindsey
    Tan, Aik Choon
    Arcaroli, John J.
    Purkey, Alicia
    Messersmith, Wells A.
    Ecsedy, Jeffery A.
    Eckhardt, S. Gail
    ONCOTARGET, 2016, 7 (31) : 50290 - 50301
  • [5] Antitumor activity of novel Akt inhibitor, perifosine in gastric cancer cell lines
    Kim, Tae Soo
    Kim, Hyo Song
    Kwan, Bo Ram
    Park, Chan Hee Park
    Jeung, Hei-Cheul Jeung
    Jang, Woo Ick
    Enge, Juergen
    Chung, Hyun Cheol
    Roh, Jae Kyung
    Rha, Sun Young
    CANCER RESEARCH, 2011, 71
  • [6] Discovery of Dabrafenib: A Selective Inhibitor of Raf Kinases with Antitumor Activity against B-Raf-Driven Tumors
    Rheault, Tara R.
    Stellwagen, John C.
    Adjabeng, George M.
    Hornberger, Keith R.
    Petrov, Kimberly G.
    Waterson, Alex G.
    Dickerson, Scott H.
    Mook, Robert A., Jr.
    Laquerre, Sylvie G.
    King, Alastair J.
    Rossanese, Olivia W.
    Arnone, Marc R.
    Smitheman, Kimberly N.
    Kane-Carson, Laurie S.
    Han, Chao
    Moorthy, Ganesh S.
    Moss, Katherine G.
    Uehling, David E.
    ACS MEDICINAL CHEMISTRY LETTERS, 2013, 4 (03): : 358 - 362
  • [7] A new small-molecule Aurora B inhibitor shows antitumor activity in human cancer cell lines
    Wu, Yuanyuan
    Li, Jie
    Jiang, Chenxiao
    Yang, Xianmei
    Cao, Lihuan
    Yu, Long
    MOLECULAR BIOLOGY REPORTS, 2015, 42 (02) : 517 - 524
  • [8] A new small-molecule Aurora B inhibitor shows antitumor activity in human cancer cell lines
    Yuanyuan Wu
    Jie Li
    Chenxiao Jiang
    Xianmei Yang
    Lihuan Cao
    Long Yu
    Molecular Biology Reports, 2015, 42 : 517 - 524
  • [9] The antitumor effects and mechanisms of the novel compound Alocasia B against gastric cancer cells
    Tang, Xu
    Liu, Han-Qiang
    Zeng, Bin
    Gao, Jian-Kun
    Zheng, Xiang-Wei
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2019, 12 (09): : 11241 - 11248
  • [10] A novel chalcone derivative has antitumor activity in melanoma by inducing DNA damage through the upregulation of ROS products
    Li, Keke
    Zhao, Shuang
    Long, Jing
    Su, Juan
    Wu, Lisha
    Tao, Juan
    Zhou, Jianda
    Zhang, JiangLin
    Chen, Xiang
    Peng, Cong
    CANCER CELL INTERNATIONAL, 2020, 20 (01)